Enantioselective Synthesis of PPAR (Peroxisome Proliferator-Activated Receptors) Agonists and Antagonists

Publisher： Bentham Science Publishers

E-ISSN： 1873-4294|14|10|1283-1293

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.14, Iss.10, 2014-05, pp. : 1283-1293

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PPAR Modulators and PPAR Pan Agonists for Metabolic Diseases: The Next Generation of Drugs Targeting Peroxisome Proliferator-Activated Receptors?

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 9, 2008-06 ,pp. : 728-749

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-&ggr; (PPAR-&ggr;) Agonists on Glycemic Control, Lipid Profile and Cardiovascular Risk

By  

Current Molecular Pharmacology, Vol. 5, Iss. 2, 2012-01 ,pp. : 272-281

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 23, Iss. 7, 2017-04 ,pp. : 1119-1124

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR) Agonists as Promising New Medications for Drug Addiction: Preclinical Evidence

By  

Current Drug Targets, Vol. 14, Iss. 7, 2013-06 ,pp. : 768-776

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic modulators of peroxisome proliferator-activated receptors (PPAR): a patent review (2008–present)

By Lamers Christina   Schubert-Zsilavecz Manfred   Merk Daniel  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 7, 2012-07 ,pp. : 803-841

Informa Healthcare

Access to resources Recommend Favorite